Triyl Irbesartan CAS 138402-10-5 Mimo>98.0% (HPLC) Irbesartan Intermediate Factory Aworan Ifihan

Triyl Irbesartan CAS 138402-10-5 Mimo>98.0% (HPLC) Ile-iṣẹ Alagbedemeji Irbesartan

Apejuwe kukuru:

Orukọ Kemikali: Tril Irbesartan

Synonyms: Triphenyl Irbesartan

CAS: 138402-10-5

Mimọ:> 98.0% (HPLC)

Irisi: Funfun si Paa-White Powder

Agbedemeji ti Irbesartan (CAS: 138402-11-6)

E-Mail: alvin@ruifuchem.com

Fi imeeli ranṣẹ si wa

Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Ipese Kemikali Ruifu Irbesartan Intermediates:
Irbesartan CAS 138402-11-6
Cyano-Irbesartan CAS 138401-24-8
Triyl Irbesartan CAS 138402-10-5
TTBB CAS 124750-51-2
Irbesartan Ẹgbẹ Pq Hydrochloride CAS 151257-01-1

Kemikali Properties:

Orukọ Kemikali	Triyl Irbesartan
Awọn itumọ ọrọ sisọ	Triphenyl Irbesartan;Irbesartan N1-Trityl Aimọ;2-Butyl-3- ((2'- (2-tryl-2H-tetrazol-5-yl)-[1,1'-biphenyl] -4-yl)methyl) -1,3-diazaspiro [4.4] kii ṣe -1-en-4-ọkan;2-Butyl-3-[[4-[2- (2-tryl-tetrazol-5-yl) phenyl] methyl] -1,3-diazaspiro [4.4] kii-1-en-4-ọkan
Nọmba CAS	138402-10-5
NỌMBA CAT	RF-PI1893
Iṣura Ipo	Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu
Ilana molikula	C44H42N6O
Òṣuwọn Molikula	670.84
iwuwo	1,20 ± 0,10 g / cm3
Ojuami farabale	834.6±75.0℃ ni 760 mmHg
Brand	Ruifu Kemikali

Awọn pato:

Nkan	Awọn pato
Ifarahan	Funfun to Pa-White Powder
Mimọ / Analysis Ọna	> 98.0% (HPLC)
Pipadanu lori Gbigbe	<1.00%
Aloku lori Iginisonu	<0.50%
Nikan Aimọ	<1.00%
Lapapọ Awọn Aimọ	<2.00%
Awọn irin Heavy	<20ppm
Infurarẹẹdi julọ.Oniranran	Ni ibamu si Eto
Igbeyewo Standard	Standard Enterprise
Lilo	Agbedemeji / Aimọ ti Irbesartan (CAS: 138402-11-6)

Package & Ibi ipamọ:

Package: Igo, apo bankanje aluminiomu, 25kg / Paali ilu, tabi gẹgẹ bi ibeere alabara

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina ati ọrinrin

Awọn anfani:

FAQ:

Ohun elo:

Trityl Irbesartan (CAS: 138402-10-5) jẹ agbedemeji tabi aimọ ti Irbesartan (CAS: 138402-11-6).Irbesartan jẹ ohun idena olugba angiotensin II (ARB) ti a tọka fun: Itọju haipatensonu, lati dinku titẹ ẹjẹ.Idinku titẹ ẹjẹ dinku eewu apaniyan ati awọn iṣẹlẹ inu ọkan ati ẹjẹ ti kii ṣe iku, nipataki awọn ikọlu ati awọn infarction myocardial.Itọju nephropathy dayabetik ni awọn alaisan haipatensonu pẹlu iru àtọgbẹ 2, omi ara creatinine ti o ga, ati proteinuria.Irbesartan jẹ idagbasoke nipasẹ Sanofi Iwadi (bayi apakan ti Sanofi-Aventis).O jẹ tita ni apapọ nipasẹ Sanofi-Aventis ati Bristol-Myers Squibb labẹ awọn orukọ iṣowo Aprovel, Karvea, ati Avapro.